Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $2.3 million.

  • Collegium Pharmaceutical's Other Non-Current Assets fell 4394.63% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 4394.63%. This contributed to the annual value of $8.4 million for FY2024, which is 69923.59% up from last year.
  • Collegium Pharmaceutical's Other Non-Current Assets amounted to $2.3 million in Q3 2025, which was down 4394.63% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Other Non-Current Assets registered a high of $8.4 million during Q4 2024, and its lowest value of $1.0 million during Q2 2023.
  • For the 5-year period, Collegium Pharmaceutical's Other Non-Current Assets averaged around $2.7 million, with its median value being $2.5 million (2021).
  • Per our database at Business Quant, Collegium Pharmaceutical's Other Non-Current Assets plummeted by 5889.28% in 2023 and then skyrocketed by 69923.59% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Other Non-Current Assets (Quarter) stood at $2.5 million in 2021, then changed by 0.0% to $2.5 million in 2022, then crashed by 58.89% to $1.0 million in 2023, then soared by 699.24% to $8.4 million in 2024, then crashed by 72.06% to $2.3 million in 2025.
  • Its Other Non-Current Assets stands at $2.3 million for Q3 2025, versus $3.8 million for Q2 2025 and $5.0 million for Q1 2025.